Back to top
Read MoreHide Full Article

Leading semiconductor products provider, Cavium, Inc. (CAVM - Free Report) , has recently extended the OCTEON Fusion family by incorporating several technology-enabled solutions in a single product.

The new product is a reference design for ready small cells and is a Dual-RAT (Robust Audio Tool) solution supporting both LTE (Long-term Evolution) and WCDMA (Wideband Code Division Multiple Access) solutions simultaneously in addition to 3G. By incorporating 3G support in the dual solution, Cavium has broadened its competence in its already widely installed enterprise-class LTE small cell SoC (System on Chip).

The new family of OCTEON Fusion processor is cost effective and also alerts the user about power consumption. It also has the facility to support around 128 active users.  

With the launch of this product, Cavium expects to help its customers to expand their market share in the fast-growing small cell solutions market. Cavium has made production-ready samples of the new processor available in the market to launch commercial cell devices for its customers without any time lag.

California based Cavium manufactures semiconductors that run networking, communications and the digital home products. Cavium product portfolio consists of a wide variety of integrated processors with operations ranging from 100 Mbps to over 100 Gbps with compatibility in equipments like broadband/consumer and access and service provider equipment.

Cavium currently carries a Zacks Rank #3 (Hold). Some other stocks within the sector worth a look are Integrated Device Technology, Inc. (IDTI - Free Report) , OmniVision Technologies, Inc. both carrying a Zacks Rank #1 (Strong Buy) and FormFactor Inc. (FORM - Free Report) , which retains a Zacks Rank #2 (Buy).

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

FormFactor, Inc. (FORM) - free report >>

Cavium, Inc. (CAVM) - free report >>

Integrated Device Technology, Inc. (IDTI) - free report >>

More from Zacks Analyst Blog

You May Like